3BARTZOKIS G,TISHLER T A.MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer' s and Huntington's disease[J].Cell Mol Biol,2000,(46):821-823.
4BARTZOKIS G,SULTZER D,CUMMINGS J,et al.Invivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging[J].Arch Gen Psychiatry,2000,57 (1):47-53.
5HAACKE E M,XU Y,CHENG Y C,et al.Susceptibility weighted imaging (SWl)[J].Magn Reson Med,2004,52 (3):612-618.
6SEHGAL V,DELPROPOSTO Z,HAACKE E M,et al.Clinical applications of neuroimaging with susceptibilityweighted imaging[J].Magn Reson Imaging,2005,22 (4):439-450.
7BARBIKIAN T,TREIER M C,TONG K A,et al.Susceptibility weighted imaging:neuropsychologic outcome and pediatric head injury[J].Pediatr Neurol,2005,33(3):184-194.
8HAACKE E M,CHENG N Y,HOUSE M J,et al.Imaging iron stores in the brain using magnetic resonance imaging[J].Magn Reson Imaging,2005,23(1):1-25.
9GUPTA R K,RAP S B,JAIN R,et al.Differentiation of calcification from chronic hemorrhage with corrected gradient echo phase imaging[J].Comput Assist Tomogr,2001,25 (5):698-704.
10HALLGREN B,SOURANDER P.The effect of age on the non-haemin iron in the human brain[J].Neurochem,1958,(3):41-51.
